InspireMD Inc.
NSPR
4
|
$2.1409
-1.81%
16K
|
Health Technology
(0.0% 1d) (-4.3% 1m) (118.8% 1y) (0.0% 2d) (0.0% 3d) (-2.6% 7d) (41.96% volume)
Earnings Calendar: 2022-11-07
Market Cap: $ 50,218,214
http://www.inspiremd.com
Sec Filling | Patents | 48 employees
InspireMD, Inc. is a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.
israel treatment
add to watch list Paper trade email alert is off
Press-releases
Flow Diversion Aneurysm Treatment Market to grow by USD 2.11 billion from 2022 to 2027, North America to account for 38% of market growth - Technavio
Published: 2023-09-24 (Crawled : 04:20) - prnewswire.com
NSPR 4 | $2.1409 -1.81% 16K
|
Health Technology
| Email alert
Add to watchlist
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
| Email alert
Add to watchlist
TRUMY | $16.507 0.79% 34K
|
Manufacturing
| Email alert
Add to watchlist
TRUMF | $16.928 -17.59% 1.9K
|
Health Technology
| Email alert
Add to watchlist
america treatment flow growth market
InspireMD to Report Second Quarter 2022 Financial Results on August 9, 2022, and Provide Corporate Business Update
Published: 2022-08-02 (Crawled : 12:20) - globenewswire.com
NSPR 4 | $2.1409 -1.81% 16K
|
Health Technology
|
| O: 1.69%
H: 2.22%
C: -2.78%
report update results
InspireMD to Report First Quarter 2022 Financial Results on May 10, 2022 and Provide Corporate Business Update
Published: 2022-04-28 (Crawled : 21:00) - globenewswire.com
NSPR 4 | $2.1409 -1.81% 16K
|
Health Technology
|
| O: -2.33%
H: 4.33%
C: 1.59%
report results
InspireMD to Host Key Opinion Leader Event on Carotid Artery Disease Management and Stroke Prevention in combination with the CGuard™ Stent Platform & MicroNet™ Portfolio
Published: 2022-03-16 (Crawled : 21:00) - globenewswire.com
NSPR 4 | $2.1409 -1.81% 16K
|
Health Technology
|
| O: -2.69%
H: 12.65%
C: 11.07%
disease stroke one platform
InspireMD Reports Fourth Quarter and Year-End 2021 Financial Results
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
NSPR 4 | $2.1409 -1.81% 16K
|
Health Technology
|
| O: 1.14%
H: 1.12%
C: -2.44%
financial results report results
InspireMD to Report Fourth Quarter and Full Year 2021 Financial Results on March 8, 2022 and Provide Corporate Business Update
Published: 2022-02-22 (Crawled : 22:00) - globenewswire.com
NSPR 4 | $2.1409 -1.81% 16K
|
Health Technology
|
| O: 1.21%
H: 0.0%
C: -4.4%
financial results report results
InspireMD Announces Adnan Siddiqui, MD, PhD as a Member of its Scientific Advisory Board and Strategic Advisor
Published: 2022-02-15 (Crawled : 14:30) - globenewswire.com
NSPR 4 | $2.1409 -1.81% 16K
|
Health Technology
|
| O: -1.5%
H: 6.84%
C: 3.42%
ces
InspireMD to Report Second Quarter 2021 Financial Results on Tuesday, August 10, 2021, and Provide Corporate Update
Published: 2021-08-04 (Crawled : 14:15) - globenewswire.com
NSPR 4 | $2.1409 -1.81% 16K
|
Health Technology
|
| O: 0.53%
H: 0.79%
C: -1.05%
financial results results
InspireMD Enrolls and Treats First Patients at Ballad Health System in U.S. Registration C-Guardian Clinical Trial of CGuard EPS
Published: 2021-07-23 (Crawled : 13:00) - globenewswire.com
NSPR 4 | $2.1409 -1.81% 16K
|
Health Technology
|
| O: -0.43%
H: 4.76%
C: -6.28%
trial enroll
InspireMD to Present at the LD Micro Virtual Invitational Conference on June 9, 2021
Published: 2021-06-02 (Crawled : 12:15) - globenewswire.com
NSPR 4 | $2.1409 -1.81% 16K
|
Health Technology
|
| O: -1.13%
H: 2.67%
C: 0.95%
conference
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Last 48 Hours Insiders Buying
BCDA | $0.377 -1.4% 97K
|
Health Technology
|
22:00
CLSD | $1.29 -2.27% -2.33% 230K
|
Health Technology
|
14:00
CDZI P 25000 | $2.25 0.0% 260K
|
Utilities
|
14:00
ETST P 39000 | $0.068 -67.14% 43K
|
Manufacturing
|
13:30
FNLC P 1275 | $22.97 3.66% 3.53% 21K
|
Finance
|
12:30
ADMQ | $0.0532 -40.18% 480K
|
|
10:30
AXR P 2400 | $21.0 -5.28% 0.0% 13K
|
Finance
|
21:00
QCRH P 118 | $57.315 3.44% 3.32% 66K
|
Finance
|
18:01
VUZI P 7500 | $1.19 -5.56% -5.88% 550K
|
Electronic Technology
|
18:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10